<VariationArchive VariationID="11451" VariationName="NM_001099857.5(IKBKG):c.120_129dup (p.Glu44fs)" VariationType="Duplication" Accession="VCV000011451" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26490" VariationID="11451">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001099857.5(IKBKG):c.120_129dup (p.Glu44fs)</Name>
      <CanonicalSPDI>NC_000023.11:154552119:CACCTGCCTTCA:CACCTGCCTTCACCTGCCTTCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154552119" stop="154552120" display_start="154552119" display_stop="154552120" variantLength="10" positionVCF="154552119" referenceAlleleVCF="G" alternateAlleleVCF="GCACCTGCCTT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153780334" stop="153780335" display_start="153780334" display_stop="153780335" variantLength="10" positionVCF="153780334" referenceAlleleVCF="G" alternateAlleleVCF="GCACCTGCCTT" />
      </Location>
      <OtherNameList>
        <Name>10-BP INS, NT127</Name>
      </OtherNameList>
      <ProteinChange>E112fs</ProteinChange>
      <ProteinChange>E44fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.153780337_153780346dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.153780337_153780346dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.154552122_154552131dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.154552122_154552131dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009015.2" sequenceAccession="NG_009015" sequenceVersion="2" change="g.444_453dup">
            <Expression>NG_009015.2:g.444_453dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.14879_14888dup">
            <Expression>NG_009896.1:g.14879_14888dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099856.6" sequenceAccession="NM_001099856" sequenceVersion="6" change="c.324_333dup">
            <Expression>NM_001099856.6:c.324_333dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093326.2" sequenceAccession="NP_001093326" sequenceVersion="2" change="p.Glu112fs">
            <Expression>NP_001093326.2:p.Glu112fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001099857.5" sequenceAccession="NM_001099857" sequenceVersion="5" change="c.120_129dup" MANESelect="true">
            <Expression>NM_001099857.5:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001093327.1" sequenceAccession="NP_001093327" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001093327.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145255.4" sequenceAccession="NM_001145255" sequenceVersion="4" change="c.120_129dup">
            <Expression>NM_001145255.4:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138727.1" sequenceAccession="NP_001138727" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001138727.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321396.3" sequenceAccession="NM_001321396" sequenceVersion="3" change="c.120_129dup">
            <Expression>NM_001321396.3:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308325.1" sequenceAccession="NP_001308325" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001308325.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321397.3" sequenceAccession="NM_001321397" sequenceVersion="3" change="c.120_129dup">
            <Expression>NM_001321397.3:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308326.1" sequenceAccession="NP_001308326" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001308326.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377312.1" sequenceAccession="NM_001377312" sequenceVersion="1" change="c.120_129dup">
            <Expression>NM_001377312.1:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364241.1" sequenceAccession="NP_001364241" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001364241.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377313.1" sequenceAccession="NM_001377313" sequenceVersion="1" change="c.120_129dup">
            <Expression>NM_001377313.1:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364242.1" sequenceAccession="NP_001364242" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001364242.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377314.1" sequenceAccession="NM_001377314" sequenceVersion="1" change="c.120_129dup">
            <Expression>NM_001377314.1:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364243.1" sequenceAccession="NP_001364243" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001364243.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001377315.1" sequenceAccession="NM_001377315" sequenceVersion="1" change="c.120_129dup">
            <Expression>NM_001377315.1:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001364244.1" sequenceAccession="NP_001364244" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_001364244.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003639.4" sequenceAccession="NM_003639" sequenceVersion="4" change="c.120_129dup">
            <Expression>NM_003639.4:c.120_129dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003630.1" sequenceAccession="NP_003630" sequenceVersion="1" change="p.Glu44fs">
            <Expression>NP_003630.1:p.Glu44fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165197.1" sequenceAccession="NR_165197" sequenceVersion="1" change="n.261_270dup">
            <Expression>NR_165197.1:n.261_270dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009896.1" sequenceAccession="NG_009896" sequenceVersion="1" change="g.14877_14886dup">
            <Expression>NG_009896.1:g.14877_14886dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_70" sequenceAccession="LRG_70">
            <Expression>LRG_70:g.14879_14888dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300248.0003" DB="OMIM" />
        <XRef Type="rs" ID="2070949441" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff used the trace in the supplementary material from The International Incontinentia Pigmenti Consortium, 2000 (PubMed 10839543) to establish an HGVS expression for this allele.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001099857.5(IKBKG):c.120_129dup (p.Glu44fs) AND Incontinentia pigmenti syndrome" Accession="RCV000012204" Version="15">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-05-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-05-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10839543</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32438" SubmissionDate="2017-09-13" DateLastUpdated="2024-07-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300248.0003_INCONTINENTIA PIGMENTI" title="IKBKG, 10-BP INS, NT127_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV000032438" DateUpdated="2024-07-29" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-05-25">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an incontinentia pigmenti (IP; 308300) proband and her affected mother, but not in unaffected sibs, The International Incontinentia Pigmenti Consortium (2000) identified a 10-bp insertion in exon 2 of the IKBKG gene, between nucleotides 127 and 128. The insertion, an exact duplication of the previous 10 nucleotides, shifts the reading frame of the protein to add 8 amino acids after residue 43 and then truncates the protein at the next in-frame stop codon.</Attribute>
              <Citation>
                <ID Source="PubMed">10839543</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, 10-BP INS, NT127</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">10-BP INS, NT127</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32438" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Preferred">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

